AI In Pharma Market Trends Include Introduction Of New Tools For Quality Control, Process Automation And More

AI In Pharma Market Report 2021: COVID-19 Growth And Change

AI In Pharma Global Market Report 2021: COVID-19 Growth And Change

The Business Research Company’s AI In Pharma Global Market Report 2021: COVID-19 Growth And Change

LONDON, GREATER LONDON, UK, February 22, 2021 /EINPresswire.com/ — New year, new updates! Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports

Read More On The Global AI In Pharma Market Report: https://www.thebusinessresearchcompany.com/report/ai-in-pharma-global-market-report

Companies operating in the AI for the pharma market are introducing new AI tools that will be beneficial for the pharma companies. This is a key trend in the artificial intelligence in drug discovery market. AI helps in quality control, predictive maintenance, waste reduction, design optimization and process automation. For instance, in September 2019, Novartis and Microsoft announced a multiyear alliance that will leverage data & Artificial Intelligence (AI) to transform how medicines are discovered, developed and commercialized. Further, Novartis also established an AI Innovation Lab to empower associates to use AI across their business. Therefore, companies operating in the market are continuously focusing on introducing new technologies to survive in the AI in pharma market.

The major players covered in the global AI in pharma and biotech market are Novartis, IBM Watson, Microsoft Corporation, Merck, GNS Healthcare., Google, AstraZeneca, Atomwise Inc., Exscientia, Cyclica, NVIDIA Corporation, XtalPi Inc., BenevolentAI, Cloud Pharmaceuticals Inc, BERG LLC, Bayer, Pfizer, Recursion Pharmaceuticals Inc., Bristol-Myers Squibb.

The global artificial intelligence in pharma market is expected to grow from $0.91 billion in 2020 to $1.27 billion in 2021 at a compound annual growth rate (CAGR) of 39%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The AI in pharmaceuticals market size is expected to reach $5.94 billion in 2025 at a CAGR of 47%.

The artificial intelligence (AI) in pharma market covered in the AI in drug discovery market report is segmented by technology into context-aware processing, natural language processing, querying method, deep learning; by drug type into small molecule, large molecule; by application into diagnosis, clinical trial research, drug discovery, research and development, epidemic prediction.

AI In Pharma Global Market Report 2021: COVID-19 Growth And Change is one of a series of new reports from The Business Research Company that provides AI in pharma market overview, forecast AI in pharma market size and growth for the whole market, AI in pharma market segments, and geographies, AI in pharma market trends, AI in pharma market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request For A Sample Of The Global AI In Pharma Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3887&type=smp

Here Is A List Of Similar Reports By The Business Research Company:
Artificial Intelligence (AI) In Drug Discovery Global Market Report 2020-30: COVID-19 Growth And Change
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-drug-discovery-global-market-report-2020-30-covid-19-growth-and-change

Smart Pills Global Market Report 2021: COVID 19 Growth And Change to 2030
https://www.thebusinessresearchcompany.com/report/smart-pills-global-market-report-2020-30-covid-19-impact-and-recovery

Artificial Intelligence Services Global Market Report 2021: COVID 19 Growth And Change to 2030
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-services-market-global-report-2020-30-covid-19-growth-and-change

Pharmaceuticals Market – By Type (Pharmaceutical Drugs, Biologics), By Type Of Pharmaceutical Drugs (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorder Drugs, Central Nervous System Drugs, Oncology Drugs, Ophthalmology Drugs, Respiratory Diseases Drugs), By Type Of Biologics Drugs (Monoclonal Antibodies (MAbs), Therapeutic Proteins, Vaccines), And By Region, Opportunities And Strategies – Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/pharmaceuticals-market

Biotechnology Services Global Market Report 2021: COVID 19 Impact and Recovery to 2030
https://www.thebusinessresearchcompany.com/report/biotechnology-services-global-market-report-2020-30-covid-19-growth-and-change

Interested to know more about The Business Research Company?
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology. TBRC excels in company, market, and consumer research.

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn

Leave a Reply

Your email address will not be published. Required fields are marked *